Results 41 to 50 of about 13,546 (186)
Treatment of Corticosteroid Non-responsive Relapse of Neuromyelitis Optica with Intravenous Gamma Globulin – a Case Report [PDF]
Folia Medica, 2020 We report a case of a patient with a relapse of neuromyelitis optica. The relapse was initially treated with intravenous corticosteroids. A therapy with intravenous gamma globulin was started as there was no symptomatic improvement. The patient responded
Maria Dimitrova, Dobromir Iliev
doaj +3 more sources
The Treatment of Neuromyelitis Optica [PDF]
Journal of Neuro-Ophthalmology, 2014 Neuromyelitis optica (NMO) is an autoimmune disorder of the central nervous system directed against astrocytes. Initially diagnosed in individuals with monophasic or relapsing optic neuritis and transverse myelitis, NMO is now recognized as a demyelinating disorder with pleiotropic presentations due to the identification of a specific autoantibody ...
Markus C, Kowarik +2 more
openaire +2 more sources
Immunotherapy of Neuromyelitis Optica [PDF]
Autoimmune Diseases, 2013 Neuromyelitis optica (NMO) is a chronic inflammatory disease of the central nervous system that affects the optic nerves and spinal cord resulting in visual impairment and myelopathy. There is a growing body of evidence that immunotherapeutic agents targeting T and B cell functions, as well as active elimination of proinflammatory molecules from the ...
Benjamin Bienia, Roumen Balabanov
openaire +2 more sources
Biomarkers for neuromyelitis optica: a visual analysis of emerging research trends
Neural Regeneration ResearchNeuromyelitis optica is an inflammatory demyelinating disease of the central nervous system that differs from multiple sclerosis. Over the past 20 years, the search for biomarkers for neuromyelitis optica has been ongoing.
Xiangjun Li +6 more
doaj +1 more source
Journal of Medical Case Reports, 2019 Background Neuromyelitis optica spectrum disorders are severe autoimmune inflammatory diseases of the central nervous system associated with the presence of immunoglobulin G antibodies against the water channel protein aquaporin-4.
Susanne Bejerot +6 more
doaj +1 more source
The efficacy of rituximab in the therapy of neuromyelitis optica in a patient with Sjogren's syndrome: case-report and literature review [PDF]
Терапевтический архив, 2018 This case is the first description of the successful anti-B-cell therapy with rituximab in a patient with Sjogrenʼs syndrome and neuromyelitis optica spectrum disorder in Russia.
A V Torgashina, V I Vasilyev
doaj +1 more source
Neuromyelitis Optica in a Nepalese Man
Case Reports in Neurological Medicine, 2017 Background. Neuromyelitis optica is a severely disabling inflammatory disorder of the central nervous system of autoimmune etiology that mainly affects the optic nerves and spinal cord. Here, we present a case report detailing a patient with tingling and
Yogesh Subedi +4 more
doaj +1 more source
SAGE Open Medical Case Reports, 2020 The aim of this study was to examine the effect of electrical muscle stimulation on muscle atrophy caused by neuromyelitis optica. Two neuromyelitis optica patients with flaccid paralysis participated.
Kana Michiue, Yuichi Nishikawa
doaj +1 more source
The Indian Anaesthetists Forum, 2021 Neuromyelitis optica (NMO), a rare devastating demyelinating syndrome involving optic neuritis and myelitis, poses a challenge to anesthesiologists. Here, we present the anesthetic management of a diagnosed case of NMO posted for total hip replacement.
Kalyani Manasa Rapeti +4 more
openaire +2 more sources
Neural Regeneration ResearchNeuromyelitis optica spectrum disorders are neuroinflammatory demyelinating disorders that lead to permanent visual loss and motor dysfunction. To date, no effective treatment exists as the exact causative mechanism remains unknown.
Li Xu, Huiming Xu, Changyong Tang
doaj +1 more source